(WBA: B1/BB-; Stable)
It had only set aside $79m so this will be a (somewhat sizeable) credit negative. The summary is it had a contract with a health co for covid testing services, then insourced some of it, was sued for diverting tests away from the client. In March 2024, arbitrator awarded the health-co $988m but Walgreens went to Federal courts alleging the damages should be contractually limited to $79m (hence previsioned for that amount). Ruling yesterday upheld the $988m award. It is considering now taking it the court of appeals - which would likely take two-years or more it says.
Co is struggling to break a streak of bad news.
Find more articles and bullets on these widgets:
Heavy option volumes reported Friday, SOFR outpacing Treasury flows with the former leaning towards downside puts as underlying futures retreated towards post data lows late in the session. Projected rate cuts through mid-2025 have retreated since this morning's data, current vs. morning levels* as follows: Jan'25 at -0.7bp (-1.7bp), Mar'25 -6.3bp (-10.1bp), May'25 -10.5bp (-15.9bp), Jun'25 -18.2bp (-25.6bp), Jul'25 -20.2bp (25.5bp).
A clear downtrend in JGB futures remains intact and the latest fresh cycle lows, reinforces this condition. Note too that moving average studies on the continuation chart are in a bear-mode setup, highlighting a clear downtrend. The move down exposes the 140.00 psychological handle next. For bulls, a reversal would open 142.73 and 144.48, the Dec 9 and Nov 11 high respectively.